Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Systemic antitumor therapy
5 evidence topics · 6 sources
Chemotherapy and targeted agents for functioning pancreatic neuroendocrine tumors: ENETS 2023 guidance
Cytotoxic chemotherapy and sunitinib in malignant insulinoma: effect on hypoglycemia
“Historically, (combinations of) 5-fluorouracil, doxorubicin, and streptozotocin have been used for the treatment for inoperable functioning and nonfunctioning pancreatic high-grade NET, including malignant insulinomas” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, these drugs and their combinations cause considerable toxicities.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Again, it can be expected that considerable debulking following chemotherapy will be associated with less frequent and less severe hypoglycemias.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In contrast to everolimus, sunitinib does not directly influence insulin secretion or insulin resistance.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Chemotherapeutic regimes including streptozocin, 5‐fluorouracil, capecitabine and temozolomide (CAPTEM) and cisplatin with etoposide have been used in the management of metastatic neuroendocrine tumour alongside everolimus and somatostatin analogues, though evidence for their independent effect on hypoglycaemia is lacking” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Capecitabine-temozolomide, other chemotherapy, and streptozocin in malignant insulinoma: Mayo Clinic cohort
“PRRT demonstrated the highest efficacy in controlling hypoglycemia (93%), followed by CAPTEM (68%) and everolimus (62%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“SSA, chemotherapy, and streptozocin were less effective, with hypoglycemic improvement seen in 37.5, 33.3, and 28.6% of patients, respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“In contrast, chemotherapy and streptozocin-based therapies had significantly shorter OS times of 15.23 and 8.35 months, respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote